 |
PeptiVirPeptiVir, Inc. is an early stage biopharmaceutical company focused on the development and commercialization of a conformationally-constrained, synthetic peptide-based vaccine platform for the prevention of viral diseases. PeptiVir’s lead product, PVI-1000, has the potential to be a “universal” influenza vaccine wherein one or two administrations could lead to sustained protection against multiple seasonal and pandemic strains. This is in contrast to existing influenza vaccines that must be generated and administered yearly and induce antibodies that provide protection only against that year’s seasonal flu strains. PVI-1000 is predicted to work by inducing cross-reactive antibodies that would protect against multiple influenza virus strains. |
 |
Sophono
Sophono, Inc. has developed the world’s first non-percutaneous, implantable, bone-anchored hearing device. The Alpha 1 System, which was initially developed in Germany and received its CE mark in 2006 and received its FDA 510(k) clearance in May 2011, eliminates the problematic abutment of other devices by using magnets to securely affix the external sound processor to a titanium implant. |
 |
VetDCVetDC, a Colorado State University start-up headquartered in Fort Collins, Colorado, is a product development company focused on in-licensing, developing and commercializing novel biotechnologies to address serious unmet medical needs in companion animals. VetDC makes use of CSU expertise in furthering development of its cancer-focused veterinary product company; its first product was licensed from Gilead to treat lymphoma. |
 |
Flashback TechnologiesFlashback Technologies, Inc. is a development-stage medical IT company focused on advancing development of its Cardiovascular Reserve Monitor proprietary learning framework for the real-time analysis of physiological data. The Cardiovascular Reserve Monitor is directed at improving clinical outcomes for trauma patients with unrecognized hemorrhage, as well as other forms of volume loss. |
Your Company
Ecomonmic Development Through Innovation Advancement
CID4 Is Focused On
Advancing the Colorado life science ecosystem through company creation and job growth. Active management, consulting services and capital work in tandem to bridge the gap between discovery and commercialization.
Our Passion Is
Assisting outstanding life science entrepreneurs and academicians; to help turn promising ideas and discoveries into market-defining and market-leading companies
.
CID4’s Team Are
Experienced life science technology leaders, entrepreneurs and investors. We know from first-hand experience the joys (and pains) of starting and growing life science companies.